Mersana shares plunge after cancer trial death prompts FDA hold
July 19, 2018 at 09:35 AM EDT
The Cambridge biotech said an FDA investigator had determined that the death was possibly related to the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.